Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sandoz
Sandoz
Novartis brings on 8 business vets for Sandoz's new board, including 4 women
Fierce Pharma
Tue, 05/16/23 - 12:12 pm
Novartis
Sandoz
biosimilars
generics
women executives
Sandoz taps Evotec in long-term biosimilar development and manufacturing deal
Fierce Pharma
Wed, 05/10/23 - 10:00 am
Novartis
Sandoz
Evotec
biosimilars
Novartis spruces up Sandoz—again—by bringing 6 new US generics into the fold
Fierce Pharma
Thu, 05/4/23 - 09:00 pm
Novartis
Sandoz
generics
Adalvo
Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents
Yahoo/Benzinga
Wed, 05/3/23 - 10:41 pm
Amgen
Sandoz
legal
Prolia
Xgeva
patents
denosumab
Amgen nabs appeals win against Otezla generics, blocking Sandoz and Zydus copycats until 2028
Fierce Pharma
Thu, 04/20/23 - 11:47 am
Amgen
Otezla
immunology
generics
Sandoz
Zydus
patents
Sandoz to pay Allergan, Duke University $39M over eye drug lawsuit, jury says
Endpoints
Mon, 04/3/23 - 10:46 pm
Sandoz
Allergan
Duke University
legal
patents
Latisse
Sandoz, betting on biosimilar sales, to build new production plant
BioPharma Dive
Thu, 03/9/23 - 09:15 pm
Sandoz
Novartis
drug manufacturing
Slovenia
biosimilars
Sandoz files biosimilar of Amgen osteoporosis drug in US
Pharmaphorum
Tue, 02/7/23 - 12:22 pm
Sandoz
Novartis
biosimilars
osteoporosis
Prolia
Xgeva
FDA
Novartis Reports Mixed Bag Q4 Earnings, Forecasts Higher Sales, Profits Ahead Of Sandoz Spin-Off
Yahoo/Benzinga
Wed, 02/1/23 - 10:39 am
Novartis
earnings
Sandoz
Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio
Endpoints
Wed, 01/25/23 - 10:44 am
Sandoz
Novartis
Astellas
antifungals
Mycamine
generics
JPM23: Is Novartis weighing respiratory, eye drug sell-offs after Sandoz? Not necessarily, CEO says
Fierce Pharma
Mon, 01/9/23 - 10:43 pm
Novartis
JPMHC 2023
Sandoz
Respiratory
eye health
As CEO Schultz eyes retirement, Teva taps former Sandoz head Francis as its next leader
Fierce Pharma
Mon, 11/21/22 - 10:30 am
Pharma CEOs
Teva Pharmaceutical
Kåre Schultz
Richard Francis
Sandoz
AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others
Endpoints
Mon, 10/31/22 - 04:22 pm
AbbVie
Orilissa
generics
Sandoz
Teva Pharmaceuticals
endometriosis
Sun, Camber join growing list of companies reporting Adderall supply problems
Fierce Pharma
Fri, 10/7/22 - 10:50 am
ADHD
Adderall
drug shortages
Sandoz
Sun Pharma
Novartis
A perfect storm: Europe's generic industry weighs cuts to output amid energy crisis, pricing pressures and more
Fierce Pharma
Wed, 09/28/22 - 11:38 am
generics
Europe
Teva Pharmaceutical
Sandoz
Unsealed documents detail Biogen's fight against Sandoz Tysabri biosimilar
Endpoints
Tue, 09/20/22 - 08:36 pm
Biogen
Novartis
Sandoz
biosimilars
Tysabri
MS
multiple sclerosis
Sandoz reports data from Phase I/III trial of denosumab for osteoporosis
Clinical Trials Arena
Tue, 09/20/22 - 10:07 am
Novartis
Sandoz
clinical trials
biosimilarts
denosumab
osteoporosis
Novartis cuts manufacturing jobs, closes North Carolina plant ahead of Sandoz spinoff
Fierce Pharma
Fri, 08/26/22 - 10:45 am
Novartis
drug manufacturing
Sandoz
generics
It's a spinoff: Novartis parts ways with Sandoz just as its generics biz shows signs of recovery
Fierce Pharma
Thu, 08/25/22 - 11:30 am
spinoffs
Novartis
Sandoz
generics
FDA reviewing higher dose Hyrimoz biosimilar
Biopharma Reporter
Fri, 07/22/22 - 11:14 am
FDA
Sandoz
biosimilars
Hyrimoz
Humira
AbbVie
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »